My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Antihypertensive therapy and the risk of new-onset diabetes.

    Sarafidis PA, Bakris GL.

    Diabetes Care. 2006 May;29(5):1167-9. No abstract available. PMID: 16644658 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [New-onset diabetes mellitus during antihypertensive treatment]

    Düsing R.

    Dtsch Med Wochenschr. 2007 Mar 30;132(13):689-95. Review. German. No abstract available. PMID: 17377883 [PubMed - indexed for MEDLINE]Related articles

    3.

    In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.

    Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Lindholm LH, Dahlöf B; LIFE Study Investigators.

    Hypertension. 2007 Nov;50(5):984-90. Epub 2007 Sep 24.PMID: 17893425 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics.

    Phillips RA.

    Arch Intern Med. 2006 Nov 13;166(20):2174-6. No abstract available. PMID: 17101933 [PubMed - indexed for MEDLINE]Related articles

    5.

    [A problem that should be recognized. Greater risk of diabetes with antihypertensive drugs?]

    [No authors listed]

    MMW Fortschr Med. 2004 Dec 16;146(51-52):50-1. German. No abstract available. PMID: 15675247 [PubMed - indexed for MEDLINE]Related articles

    6.

    A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.

    Bangalore S, Parkar S, Grossman E, Messerli FH.

    Am J Cardiol. 2007 Oct 15;100(8):1254-62. Epub 2007 Aug 10.PMID: 17920367 [PubMed - indexed for MEDLINE]Related articles

    7.

    Incident diabetes in clinical trials of antihypertensive drugs.

    Lam SK, Owen A.

    Lancet. 2007 May 5;369(9572):1513-4; author reply 1514-5. No abstract available. PMID: 17482972 [PubMed - indexed for MEDLINE]Related articles

    8.

    [The HOT study. Can increased therapeutic intensity be dangerous?]

    Klovning A, Sandvik H, Straand J.

    Tidsskr Nor Laegeforen. 1998 Nov 20;118(28):4405-6. Norwegian. No abstract available. PMID: 9889617 [PubMed - indexed for MEDLINE]Related articles

    9.

    When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk.

    Bakris GL, Sowers JR.

    Hypertension. 2004 May;43(5):941-2. Epub 2004 Mar 22. No abstract available. PMID: 15037556 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.

    Aksnes TA, Kjeldsen SE, Rostrup M, Störset O, Hua TA, Julius S.

    J Hum Hypertens. 2008 Aug;22(8):520-7. Epub 2008 May 29.PMID: 18509347 [PubMed - indexed for MEDLINE]Related articles

    11.

    Metabolic safety of antihypertensive drugs: myth versus reality.

    Stas S, Appesh L, Sowers J.

    Curr Hypertens Rep. 2006 Oct;8(5):403-8. Review.PMID: 16965727 [PubMed - indexed for MEDLINE]Related articles

    12.

    Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

    Elliott WJ, Meyer PM.

    Lancet. 2007 Jan 20;369(9557):201-7. Erratum in: Lancet. 2007 May 5;369(9572):1518. PMID: 17240286 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.

    Burke TA, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG.

    Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):979-87.PMID: 17605137 [PubMed - indexed for MEDLINE]Related articles

    14.

    The role of renin blockers in the prevention of diabetes.

    Alkhenizan AH, Alswes MA.

    Saudi Med J. 2007 Jan;28(1):91-5. Erratum in: Saudi Med J. 2007 Apr;28(4):659. PMID: 17206297 [PubMed - indexed for MEDLINE]Related articles

    15.

    Diabetogenic effect of antihypertensive treatment: primum nil nocere.

    Düsing R, Lehnert H.

    Nephrol Dial Transplant. 2004 Mar;19(3):531-4. Review. No abstract available. PMID: 14767003 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine.

    Weycker D, Edelsberg J, Vincze G, Kjeldsen SE, Jamerson K, Khan ZM, Oster G.

    J Hum Hypertens. 2007 May;21(5):374-80. Epub 2007 Feb 22.PMID: 17314999 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term safety of antihypertensive therapy.

    Grossman E, Messerli FH.

    Prog Cardiovasc Dis. 2006 Jul-Aug;49(1):16-25. Review.PMID: 16867847 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

    Arch Intern Med. 2006 Nov 13;166(20):2191-201.PMID: 17101936 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antihypertensive agents, insulin sensitivity, and new-onset diabetes.

    Sarafidis PA, McFarlane SI, Bakris GL.

    Curr Diab Rep. 2007 Jun;7(3):191-9. Review.PMID: 17547836 [PubMed - indexed for MEDLINE]Related articles

    20.

    Focus on hypertension.

    Tentori F.

    J Nephrol. 2007 Mar-Apr;20(2):135-40. No abstract available. PMID: 17514617 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity